Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies

With a rapidly growing elderly human population, the incidence of age-related lung diseases such as chronic obstructive pulmonary disease (COPD) continues to rise. It is widely believed that reactive oxygen species (ROS) play an important role in ageing and in age-related disease, and approaches of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caspar Schiffers, Niki L. Reynaert, Emiel F. M. Wouters, Albert van der Vliet
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6f3022a396f0489db2db729818152b76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f3022a396f0489db2db729818152b76
record_format dspace
spelling oai:doaj.org-article:6f3022a396f0489db2db729818152b762021-11-25T16:28:48ZRedox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies10.3390/antiox101117992076-3921https://doaj.org/article/6f3022a396f0489db2db729818152b762021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1799https://doaj.org/toc/2076-3921With a rapidly growing elderly human population, the incidence of age-related lung diseases such as chronic obstructive pulmonary disease (COPD) continues to rise. It is widely believed that reactive oxygen species (ROS) play an important role in ageing and in age-related disease, and approaches of antioxidant supplementation have been touted as useful strategies to mitigate age-related disease progression, although success of such strategies has been very limited to date. Involvement of ROS in ageing is largely attributed to mitochondrial dysfunction and impaired adaptive antioxidant responses. NADPH oxidase (NOX) enzymes represent an important enzyme family that generates ROS in a regulated fashion for purposes of oxidative host defense and redox-based signalling, however, the associations of NOX enzymes with lung ageing or age-related lung disease have to date only been minimally addressed. The present review will focus on our current understanding of the impact of ageing on NOX biology and its consequences for age-related lung disease, particularly COPD, and will also discuss the implications of altered NOX biology for current and future antioxidant-based strategies aimed at treating these diseases.Caspar SchiffersNiki L. ReynaertEmiel F. M. WoutersAlbert van der VlietMDPI AGarticleageingCOPDoxidative stressredox signallingNADPH oxidaseDUOX1Therapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1799, p 1799 (2021)
institution DOAJ
collection DOAJ
language EN
topic ageing
COPD
oxidative stress
redox signalling
NADPH oxidase
DUOX1
Therapeutics. Pharmacology
RM1-950
spellingShingle ageing
COPD
oxidative stress
redox signalling
NADPH oxidase
DUOX1
Therapeutics. Pharmacology
RM1-950
Caspar Schiffers
Niki L. Reynaert
Emiel F. M. Wouters
Albert van der Vliet
Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
description With a rapidly growing elderly human population, the incidence of age-related lung diseases such as chronic obstructive pulmonary disease (COPD) continues to rise. It is widely believed that reactive oxygen species (ROS) play an important role in ageing and in age-related disease, and approaches of antioxidant supplementation have been touted as useful strategies to mitigate age-related disease progression, although success of such strategies has been very limited to date. Involvement of ROS in ageing is largely attributed to mitochondrial dysfunction and impaired adaptive antioxidant responses. NADPH oxidase (NOX) enzymes represent an important enzyme family that generates ROS in a regulated fashion for purposes of oxidative host defense and redox-based signalling, however, the associations of NOX enzymes with lung ageing or age-related lung disease have to date only been minimally addressed. The present review will focus on our current understanding of the impact of ageing on NOX biology and its consequences for age-related lung disease, particularly COPD, and will also discuss the implications of altered NOX biology for current and future antioxidant-based strategies aimed at treating these diseases.
format article
author Caspar Schiffers
Niki L. Reynaert
Emiel F. M. Wouters
Albert van der Vliet
author_facet Caspar Schiffers
Niki L. Reynaert
Emiel F. M. Wouters
Albert van der Vliet
author_sort Caspar Schiffers
title Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
title_short Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
title_full Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
title_fullStr Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
title_full_unstemmed Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
title_sort redox dysregulation in aging and copd: role of nox enzymes and implications for antioxidant strategies
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6f3022a396f0489db2db729818152b76
work_keys_str_mv AT casparschiffers redoxdysregulationinagingandcopdroleofnoxenzymesandimplicationsforantioxidantstrategies
AT nikilreynaert redoxdysregulationinagingandcopdroleofnoxenzymesandimplicationsforantioxidantstrategies
AT emielfmwouters redoxdysregulationinagingandcopdroleofnoxenzymesandimplicationsforantioxidantstrategies
AT albertvandervliet redoxdysregulationinagingandcopdroleofnoxenzymesandimplicationsforantioxidantstrategies
_version_ 1718413143008346112